M
Mohamed A. El-Nabarawi
Researcher at Cairo University
Publications - 113
Citations - 1641
Mohamed A. El-Nabarawi is an academic researcher from Cairo University. The author has contributed to research in topics: Medicine & Chemistry. The author has an hindex of 18, co-authored 78 publications receiving 1056 citations.
Papers
More filters
Journal ArticleDOI
Promising ion-sensitive in situ ocular nanoemulsion gels of terbinafine hydrochloride: Design, in vitro characterization and in vivo estimation of the ocular irritation and drug pharmacokinetics in the aqueous humor of rabbits
TL;DR: F31 in situ NE gel showed the least ocular irritation potential and significantly (P<0.01) higher C(max, delayed T(max), prolonged mean residence time and increased bioavailability.
Journal ArticleDOI
Microemulsion and poloxamer microemulsion-based gel for sustained transdermal delivery of diclofenac epolamine using in-skin drug depot: in vitro/in vivo evaluation.
TL;DR: It is proposed that topical ME formulation, containing higher fraction of oil solubilized drug, could be promising for sustained transdermal delivery of drug.
Journal ArticleDOI
Fluconazole-loaded solid lipid nanoparticles topical gel for treatment of pityriasis versicolor: formulation and clinical study.
Shaimaa El-Housiny,Maii Atef Shams Eldeen,Yasmina Ahmed El-Attar,Hoda A Salem,Dalia A. Attia,Ehab R. Bendas,Mohamed A. El-Nabarawi +6 more
TL;DR: Findings of the study suggest that the developed FLZ loaded SLNs topical gels have superior significant fast therapeutic index in treatment of PV over commercially available Candistan® cream.
Journal ArticleDOI
Formulation and evaluation of PLA and PLGA in situ implants containing secnidazole and/or doxycycline for treatment of periodontitis.
TL;DR: Results revealed that the pharmaceutical formulation based on 25% PLGA containing secnidazole and doxycycline hydrochloride has promising activity in treating periodontitis in comparison with Atridox®.
Journal ArticleDOI
Use of transethosomes for enhancing the transdermal delivery of olmesartan medoxomil: in vitro, ex vivo, and in vivo evaluation.
TL;DR: The obtained results confirmed the potential of employing TEs as a successful carrier for the transdermal delivery of OLM and showed superiority in dermatokinetic study when compared with drug suspension.